Fresenius Medical Care AG & Co. KGaA FMS

NYS: FMS | ISIN: US3580291066   31/05/2024
21,27 USD (+0,95%)
(+0,95%)   31/05/2024

23 mei 2024 · Moody's and S&P change Fresenius Medical Care's rating outlook to stable · Persbericht

21 mei 2024 · Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024 · Persbericht

16 mei 2024 · Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets · Persbericht

7 mei 2024 · Fresenius Medical Care starts the year with strong earnings growth · Persbericht

22 maart 2024 · Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care · Persbericht

19 maart 2024 · Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device · Persbericht

13 maart 2024 · Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources · Persbericht

5 maart 2024 · Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador · Persbericht

20 februari 2024 · Fresenius Medical Care delivers on commitments in a year of fundamental transformation · Persbericht

8 februari 2024 · Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies · Persbericht

5 februari 2024 · Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board · Persbericht

8 januari 2024 · Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions · Persbericht

1 november 2023 · Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter · Persbericht

31 oktober 2023 · Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery · Persbericht

31 oktober 2023 · Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023 · Persbericht

26 oktober 2023 · Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset · Persbericht

18 oktober 2023 · Capital Square Delivers 149.59% Total Return* to Investors in Medical Building DST · Persbericht

12 oktober 2023 · Mee m/d markt :'Aftellen naar inflatiedata VS' · Bolero.be

Er was gisteren heel wat animo op de beursvloer, maar de winst op indexniveau bleef in Europa beperkt tot 0,15% en liep op tot 0,4% in de VS. Groene cijfers, dus, daags na wat de grootste dagwinst was sinds begin 2023. Gisteren...

11 oktober 2023 · Capital Square Delivers 147.63% Total Return* to Investors in Medical Building DST · Persbericht

23 augustus 2023 · Fresenius Medical Care Announces FDA Clearance of Versi®HD with GuideMe Software · Persbericht

Mijn selecties